GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
"I would leave a £40-£45bn cheeky offer on the table for 14 days and walk away."
You will be walking for a long time. I dint want to deal at £50B but now, sure £10B less is fine! Oh and dont worry about those shares you were going to give me dropping 7% either.
As a GSK shareholder too ........ your fired!
Sherlock: Its actually only 5 times revenue of the GSK arm.
I can see a higher bid of up to 68b easily.
You only worry that you may end with the gsk consumer arm if the government try to make it difficult for the Americans to buy because its has been no secret for a few years they may willing to pay around £70 billion 50 Will not but it thats a sure thing American market closed today so may have some reaction from there next few days
I do hope you are right, we do not need anymore debt unless it offers compelling returns.
£50bn seems a tad expensive, the £60bn gsk are reportedly looking for is highway robbery.
I would leave a £40-£45bn cheeky offer on the table for 14 days and walk away.
Deal won't happen as will need shareholder approval. Good time to top up.
Graeme Pitkethly has the title of CFO & Executive Director. He manages to pay himself €2.96m per year for this!
Actually Sher-lock x5 revenue & fast heading to x4.
Margin something like 25%. It is a good acquisition for someone, but Unilever can't afford to take on the debt.
We can all see that, why can't they. Who is their FD anyway? He needs kicking too. How could he recommend this?
"I hope this failure of the takeover will sweep through the management of ULVR and these guys have to leave."
Can we afford the gigantic "golden parachute" payments these no-hopers will undoubtedly cream off though?
What failure , the fat lady hasn’t finished yet.
Yes, bought lots of ULVR and kept GSK. This stupidity here now marks the time change the Board. Activists time to strike and release the value!
I hope this failure of the takeover will sweep through the management of ULVR and these guys have to leave. Everywhere the same stupid guys ruling, Nestle, L'Oreal, and so on. If you fail to grow the existing business with innovation, you move on with an expensive acquisition. The GSK business is not worth the 50 billion GBP, close to ten times revenues with what kind of margin. Read comments, the business was growing four percent per annum over the last few years.
I may be wrong, but I understand that Jope gets paid in tanker loads of vaseline rather than cash.
So the targets price is up by less than 4% & this has been hit by 8%.
Thanks Dope. Why don't you stick to what your good at?
Silly overreaction. I doubt ULVR will continue bidding for GSK and the IIs will keep up pressure on the board performace-wise. This company will continue paying great divis, long after the current negativity has passed. Took the opportunity to double my holding today.
..... Well I saw such drops even without news Homeserve started to recover. We have to pay attention to the correlation price drop vs volume. If the volume is very low then it is an enforced technical drop to scare the investors much controlled by the market maker
GLA
US market closed today so no dip expected later today due to them opening.
First, interesting that this bid info now suddenly in public domain - in whose interest? GSK obviously since indicates level of interest to rest of potential bidders and, if bid appears >£60bn then would be accepted by GSK and saves costs of splitting Company as planned. ULVR cannot afford bid higher than ca £50bn without loan support - in era of rising interest rates. Not good news for ULVR investors. Any successful bid for GSK, from whoever, would take time to complete so share prices for both ULVR and GSK liable to shift. Hold both these myself and would not reinvest in either at the moment - unless ULVR drop bid approach and still fall sub £35. Interesting to see though as the FTSE needs a good shake-up if only to let the US market know that we exist!
Cannot see how they can afford it debt is already very high. Concerning.
Good luck, I'm not putting another penny in.
Management have lost the plot here, Terry Smith was right.
Couldn't resist....never selling and 3-5 years from now ???? I am convinced will be higher than today.
"Now at a 5 year low"
£32 back in Jan 17 just sayin!
"Why did it not make an offer when GSK was at rock bottom??"
I think they had to wait until GSK decided they wanted to split off the consumer side. That eventually happened when Emma W took over and it looks like ULVR have been trying for a wee while to get something sorted. Maybe the news has been "leaked" to flush out another buyer and or to pressurise ULVR into a higher offer to get the deal over the line.
I applaud ULVR's move toward health and beauty , I just can't understand why they don't snap up Venture Life Group whilst it's available ! (VLG.l) . NB I am long VLG
+1 I've bought in today
Good timing for me, I was reading in IC over the weekend that defensive stocks are undervalued by the market and decided I needed more coverage of them in my portfolio. Lo and behold, the largest faller in the FTSE 100 day (by some margin) is one of the ones I was looking at - Unilever.
Being able to buy in here at a 5 year low is a massive bonus. A welcome addition to my portfolio at a very generous price :)
It’s fill your boots time for the future.